Rational Design of Dual Degraders by Incorporating Molecular Glue Structural Features into PROTAC Degraders

at 20 mpk significantly inhibited LNCaP xenograft tumor growth in mice without obvious toxicity. Dual AR/AR-V7 and GSPT1 degraders represent a class of promising novel mechanism compounds for further extensive evaluations in prostate cancer treatment.